6 studies found for: Open Studies | T-cell prolymphocytic leukemia | NOT transplant
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Registry of the German CLL Study Group
† Study has passed its completion date and status has not been verified in more than two years.